Effect of Real-time Continuous Glucose Monitoring on Glucose Control and Outcomes of Critically Ill Patients
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 144
- 试验地点
- 1
- 主要终点
- Glycemic Control Measures including: Percentage of target blood glucose levels (defined as between 8mmol/L and 10mmol/L); Time of hyperglycemia (defined as >10mmol/L); Hypoglycemia rate (defined as < 2.2mmol/L); Glucose lability index
研究概览
简要总结
The purpose of the study is to evaluate the effect of real-time continuous glucose monitoring system on glucose control and outcomes of critically ill patients.
详细描述
Real-time continuous glucose monitoring system has shown great accuracy and feasibility in critically ill patients. However, its impact on glucose control and outcomes has nearly unknown. Thus, Investigators designed this study to evaluate the effect of real-time continuous glucose monitoring system on glucose control and outcomes of critically ill patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •More than 18 years old male or female;
- •Expected ICU stays longer than 72 hours;
- •Glucose level more than 8 mmol/L when enrolls in the ICU;
- •Patients or their legal surrogates have signed the informed consent.
排除标准
- •Pregnant or lactating women;
- •ICU stays less than 72 hours;
- •Usage of real-time continuous glucose monitoring system is considered as a contraindication.
结局指标
主要结局
Glycemic Control Measures including: Percentage of target blood glucose levels (defined as between 8mmol/L and 10mmol/L); Time of hyperglycemia (defined as >10mmol/L); Hypoglycemia rate (defined as < 2.2mmol/L); Glucose lability index
时间窗: Glycemic control measures will be assessed up to five days.
次要结局
- Prognosis Measures including: Duration of mechanical ventilation；Time of ICU stay; Time of hospital stay; 28 days - mortality rate(All the participants will be followed for the duration of hospital stay or 28 days.)
- Cost(Cost associated with glucose monitoring)
研究者
Kang Yan
Director of Intensive Care Unit
West China Hospital